🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to evaluate the efficacy of tapentadol oral so...
Status
Completed
Location
US008
Start Date
2015-02-19
Trial ID
NCT02081391
Treatments Being Tested
The purpose of this study is to test in patients who have had hip replaceme...
Status
Terminated
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00364533
Treatments Being Tested
The purpose of this study is to determine the effectiveness and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00771758
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of im...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT01719601
Treatments Being Tested
The main objective of this study is to demonstrate the efficacy and safety ...
Status
Completed
Location
Site 13
Start Date
2007-05
Trial ID
NCT00478023
The purpose of this study is to evaluate how tapentadol immediate release (...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00814580
Treatments Being Tested
The purpose of this study is to evaluate the safety of CG5503 base Immediat...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00364546
Treatments Being Tested
Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxyc...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00986180
Treatments Being Tested
Tapentadol is FDA approved for the treatment of moderate to severe acute pa...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2011-05
Trial ID
NCT01500317
Treatments Being Tested
The purpose of this study is to compare the risk of shopping behavior of ta...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01545778
Treatments Being Tested